Ro review: separate the membership from the prescription bill

Read the recurring membership first

The page advertises $39 for the first month and $149 for subsequent monthly membership. It also shows lower monthly equivalents for prepaid commitments: $74 with twelve months, $89 with six months and $99 with three months. A monthly equivalent is a way to divide an upfront bill; it does not mean that amount is charged separately each month under the annual option.

Sources: Weight Loss Program Pricing | Ro

Medication is an additional expense

Ro explicitly says medication costs are separate. The page lists starting cash-pay figures for Wegovy pill, Foundayo pill, Wegovy pen and Zepbound KwikPen. Some injection figures relate to particular starting offers. Comparing them as if they were fixed prices for every prescription would obscure the selected product and promotion. The useful total combines membership, medication and any other applicable charge.

Sources: Weight Loss Program Pricing | Ro

For another purchase structure, read Hers and WeightWatchers Clinic. These links compare the offers, not individual health outcomes.

Oral and injection listings are distinct

The current page gives oral medicines their own place rather than treating every GLP-1 offer as a shot. An oral option still requires a prescribing decision and does not become appropriate merely because swallowing a pill seems easier. The page’s brand listings also differ from a compounded-liquid oral offer on another platform; formulation and approval status should be compared directly.

Sources: Weight Loss Program Pricing | Ro

Insurance support is a service, not coverage

Ro describes insurance assistance and clinical follow-up. Assistance with a prior authorization cannot promise an insurer’s decision, a particular copay or an uninterrupted supply. Someone bringing an existing policy should ask about the selected drug and their actual benefit. Someone paying cash should instead examine the renewal terms and medicine-specific price without counting hypothetical insurance savings.

Sources: Weight Loss Program Pricing | Ro

Keep the full cost calculation and branded-versus-compounded distinction visible. Our evidence guide explains why different result types cannot be scored as one clinical ranking.

Keep the clinical question separate

NIDDK explains that prescription weight-management treatment is intended for people with relevant health circumstances and requires a professional assessment. A convenient website does not determine that assessment. This article cannot decide whether treatment is appropriate for a reader, compare individual risks or forecast weight change. The clinician needs the actual medical history and should explain the selected product and follow-up plan.

Sources: Prescription Medications to Treat Overweight & Obesity - NIDDK

Where this review ends

This review was written from official public pages available on October 1, 2026. We did not receive patient care, test medication, inspect a pharmacy or verify a completed purchase. Prices and program descriptions can change. FDA’s warning about unapproved GLP-1 products explains a regulatory distinction; it is not independent validation of this particular provider or product. Individual benefits, risks and eligibility require a qualified clinician.

Sources: FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss